Properties (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administrativeDivision |
annual
|
| gptkbp:approves |
regulatory authorities
|
| gptkbp:clinicalTrials |
conducted prior to approval
used in veterinary medicine |
| gptkbp:contraindication |
rare severe reactions
|
| gptkbp:countermeasures |
facing challenges in distribution
|
| gptkbp:developedBy |
Vaxsafe
|
| gptkbp:diseaseResistance |
subject to veterinary regulations
|
| gptkbp:dosageForm |
liquid
|
| gptkbp:evaluates |
high_efficacy_against_IBR
|
| gptkbp:formulation |
liquid suspension
|
| gptkbp:hasEducation |
educational resources available for farmers
|
| gptkbp:healthcare |
part of routine vaccination
|
| gptkbp:history |
developed in response to IBR outbreaks
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaxsafe IBR
|
| gptkbp:label |
contains dosage instructions
|
| gptkbp:manufacturer |
gptkb:Vaxsafe_Inc.
|
| gptkbp:marketedAs |
various countries
|
| gptkbp:notable_player |
live attenuated
recommended by veterinarians store at 2-8°C funded by agricultural grants administered by a veterinarian approved for use in livestock collaborations with veterinary schools cost-effective for farmers developed for cattle health distributed through veterinary clinics monitored for safety post-approval part of innovative vaccine development proven effective in field studies reduces disease incidence subject of veterinary research |
| gptkbp:oversees |
from 3 months of age
|
| gptkbp:reproduction |
supported by veterinary community
|
| gptkbp:researchInterest |
ongoing research
|
| gptkbp:route |
subcutaneous
|
| gptkbp:safetyFeatures |
generally safe
|
| gptkbp:sideEffect |
mild reactions possible
|
| gptkbp:storage |
refrigerated
|
| gptkbp:supports |
yes
|
| gptkbp:targets |
gptkb:Infectious_Bovine_Rhinotracheitis
cattle |
| gptkbp:type |
inactivated vaccine
|
| gptkbp:usedFor |
prevention of infectious diseases
|
| gptkbp:wasAffecting |
future developments anticipated
|